BioCardia, Inc. Balance Sheet
BCDA|3 years of annual SEC 10-K data (FY2011-FY2017)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$14M
FY2017
Cash
$13M
Cash and equivalents
Total Debt
N/A
FY2017
Shareholder Equity
$11M
FY2017
BioCardia, Inc. had $14M in total assets and $11M in shareholders' equity as of FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -110.6% ROE
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2011 |
|---|---|---|---|
| Cash & Equivalents | $12.7M | $21.4M | $12.7M |
| Accounts Receivable | $95.0K | $74.0K | $67.0K |
| Inventory | $191.0K | $135.0K | - |
| Current Assets | $13.3M | $21.9M | $13.7M |
| PP&E (Net) | $169.0K | $111.0K | - |
| Total Assets | $13.5M | $22.1M | $13.7M |
| Current Liabilities | $2.3M | $1.4M | - |
| Shareholders' Equity | $11.1M | $20.6M | $13.0M |